ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1529

Systemic Lupus Erythematous and Neuromyelitis Optica Overlap and Risk of Infection in Hospitalized Patients

Elizabeth Fagin1, Wei Chapman2, fares Saliba3 and Eugenio Capitle4, 1Staten Island University Hospital, Teaneck, 2Staten Island University Hospital, Staten Island, 3Staten Island University Hospital, Staten Island, NY, 4University Hospital, Newark

Meeting: ACR Convergence 2024

Keywords: Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 17, 2024

Title: SLE – Diagnosis, Manifestations, & Outcomes Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Neuromyelitis optica (NMO) is an autoimmune inflammatory disorder that can coexist with systemic lupus erythematous (SLE). Given the immunosuppressive nature of SLE, it is therefore crucial to assess if there is an increase in infections in hospitalized patients with NMO and SLE overlap, as this has not been well studied.  This study aims to explore acute cystitis, gastrointestinal infections, upper respiratory infections, pneumonia, skin infections and severe sepsis in SLE patients with NMO overlap.

Methods: National Inpatient Sample (NIS) database was used to sample individuals with SLE and NMO and baseline comorbidities and demographics were collected using ICD-10 codes. Patients were stratified into two groups consisting of patients with SLE alone and patients with SLE/NMO overlap. Multivariate Logistic Regression analysis was performed and a p-value of < 0.05 was considered significant.

Results: Of 105,930 SLE patients included in the study 153 had Neuromyelitis Optica. SLE/NMO overlap had a higher prevalence of acute cystitis and severe sepsis compared to SLE alone.  Patients with SLE/NMO overlap were 3 times more likely to develop acute cystitis during hospitalization (adjusted OR: 3.019  [2.795-3.260]; p< 0.001) compared to SLE patients alone.  Additionally, SLE/NMO overlap patients were 2 times more likely to develop severe sepsis during hospitalization (adjusted OR: 2.072 [1.362-4.473]; p=0.017) compared to SLE patients alone.

Conclusion: Coexisting systemic lupus erythematous and neuromyelitis optica was associated with increased risk of acute cystitis and severe sepsis.  We hypothesize that a high inflammatory state and significant immunosuppression contributed to this increased risk.  Larger studies may be needed to corroborate our findings.


Disclosures: E. Fagin: None; W. Chapman: None; f. Saliba: None; E. Capitle: None.

To cite this abstract in AMA style:

Fagin E, Chapman W, Saliba f, Capitle E. Systemic Lupus Erythematous and Neuromyelitis Optica Overlap and Risk of Infection in Hospitalized Patients [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/systemic-lupus-erythematous-and-neuromyelitis-optica-overlap-and-risk-of-infection-in-hospitalized-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/systemic-lupus-erythematous-and-neuromyelitis-optica-overlap-and-risk-of-infection-in-hospitalized-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology